Introduction
Epidermolysis bullosa (EB) is a group of inherited disorders in which the skin and, in some forms, the lining of the mouth, esophagus, and other mucosal surfaces are unusually fragile. The core problem is structural: layers of the skin that normally stay firmly attached separate too easily, so minor friction or shear can lead to blistering and tissue injury. EB develops because of defects in proteins that hold skin cells together or anchor the epidermis to the underlying dermis, disrupting the mechanical stability of the skin barrier.
To understand EB, it helps to think of the skin not as a simple covering but as a layered, living organ built to resist stress. In EB, the proteins that provide that resistance are altered, absent, or insufficient. The result is a condition defined by weakness at specific junctions within the skin, with the exact level of tissue separation depending on the genetic form of the disorder.
The Body Structures or Systems Involved
The main structure affected in epidermolysis bullosa is the skin, especially the junction between the epidermis and the dermis. The epidermis is the outer cellular layer that acts as a protective barrier against dehydration, microbes, chemicals, and mechanical injury. The dermis lies underneath and provides strength, elasticity, blood supply, and support. Between them is the basement membrane zone, a specialized interface made of proteins that help the layers adhere to one another.
Healthy skin depends on tightly coordinated structural proteins. Keratin intermediate filaments inside epidermal cells distribute mechanical stress. Hemidesmosomes anchor the basal cells of the epidermis to the basement membrane. Collagen and other extracellular matrix proteins strengthen the dermal side of the junction. When these components work together, ordinary movement, pressure, and rubbing do not separate the skin layers.
EB can also involve mucosal tissues. The mouth, throat, esophagus, airway, eyes, and anogenital lining may be affected because these surfaces, like the skin, rely on similar adhesion proteins and are exposed to friction. In some forms, nails, hair follicles, and teeth are also altered, reflecting the broader role of the affected proteins in epithelial development and maintenance.
How the Condition Develops
EB develops when mutations disrupt genes that encode structural proteins of the skin. These genes vary by subtype, but they commonly include those for keratins, laminin-332, integrins, collagen VII, and proteins associated with the hemidesmosomal or basement membrane structures. Because these proteins are essential for physical cohesion, a mutation can weaken the tissue at the precise level where that protein normally functions.
The biological consequence depends on where the defect lies. If the mutation affects keratin 5 or keratin 14, the basal cells of the epidermis become mechanically fragile and may rupture within the lower epidermis. If the defect involves proteins that connect the epidermis to the basement membrane, separation tends to occur at the dermal-epidermal junction. If collagen VII is altered, the anchoring fibrils that fasten the basement membrane to the dermis fail, and the split occurs deeper, beneath the basement membrane.
Under normal conditions, skin cells respond to friction by distributing force across their internal cytoskeleton and attachment complexes. In EB, that force cannot be absorbed effectively. A small amount of shear stress may cause cells to break apart or the tissue layers to detach. Fluid then accumulates in the separation plane, producing a blister. The blister is not the primary disease process; it is the visible result of a structural failure at the molecular level.
Because the responsible proteins are encoded by genes, EB is usually present from birth or early infancy. In some variants, both copies of a gene must be altered for disease to appear, while in others a single altered copy is enough. The severity depends on whether the mutation abolishes protein production completely, reduces its quantity, or allows production of a structurally abnormal protein that still weakens tissue integrity.
Structural or Functional Changes Caused by the Condition
The most direct change caused by EB is loss of normal tissue cohesion. Instead of forming a continuous, durable barrier, the skin becomes mechanically unstable and prone to separation. Repeated injury can lead to erosions, scarring, thickening in some areas, or loss of normal architecture depending on subtype and depth of damage.
When skin injury occurs repeatedly, the repair process itself can alter tissue structure. In some forms of EB, healing is followed by fibrosis, which is the excessive deposition of connective tissue. Over time this can reduce flexibility, deform fingers or toes, and limit movement. Chronic damage to the nail matrix may lead to nail dystrophy or nail loss, while injury to the oral cavity or esophagus can cause tightening and narrowing through scarring.
Inflammation is often present as a secondary response to repeated microinjury. The body attempts to repair the damaged barrier by recruiting immune cells, generating growth signals, and producing new matrix proteins. This response is necessary for healing, but when injury recurs faster than the tissue can repair, inflammation becomes chronic and contributes to further tissue remodeling. Persistent open areas on the skin also increase water loss and make the body more vulnerable to infection because the barrier function is compromised.
In severe forms, the functional impact extends beyond the skin surface. Pain sensitivity increases because nerve endings are exposed in damaged tissue. Nutrition may be affected when mouth or esophageal involvement interferes with swallowing. Loss of the normal skin barrier can also disturb temperature regulation and fluid balance, since the skin is essential for both. These are downstream physiological effects of structural failure rather than independent disease mechanisms.
Factors That Influence the Development of the Condition
The dominant factor in EB is genetics. The condition is caused by pathogenic variants in genes that encode proteins responsible for epidermal adhesion and structural support. The specific gene involved strongly influences how the disease behaves, where tissue separation occurs, and how severe the fragility becomes. Different mutations within the same gene can also produce different levels of protein loss or dysfunction, which helps explain the wide range of clinical severity.
The inheritance pattern is another key factor. Some forms are autosomal dominant, meaning one altered gene copy can produce disease. Others are autosomal recessive, requiring two altered copies. Recessive forms often produce more severe disease because they usually involve more complete loss of protein function. Dominant forms may create an abnormal protein that interferes with the normal protein’s role or may reduce structural resilience without eliminating it entirely.
Mechanical stress influences when tissue separation occurs, but it does not cause the disorder. Friction, pressure, heat, and minor trauma expose the underlying weakness. The same inherited defect may remain clinically mild in low-stress circumstances and become more apparent with frequent rubbing or repetitive use of vulnerable areas. Environmental conditions therefore modify expression, but they do not replace the underlying genetic mechanism.
Secondary infection can also influence disease expression by worsening inflammation and slowing repair. When damaged skin is colonized by bacteria or fungi, the inflammatory response intensifies and the tissue can be injured further. Nutritional status may affect the efficiency of healing because protein, energy, and micronutrient availability are necessary for matrix synthesis and tissue repair. These factors shape the course of the disorder, but EB itself originates in defective structural biology.
Variations or Forms of the Condition
Epidermolysis bullosa is not a single disease but a family of related disorders classified by the level of skin separation and the protein involved. The major forms are EB simplex, junctional EB, dystrophic EB, and a rarer form called Kindler syndrome. Each reflects a different point of weakness in the skin’s attachment system.
In EB simplex, the split usually occurs within the epidermis. The underlying problem is often a defect in keratin proteins that support basal keratinocytes. Because the basement membrane remains intact, blistering is typically more superficial, though severity can still vary widely. Some cases are localized to the hands and feet, while others are more generalized.
In junctional EB, the separation occurs within the basement membrane zone. This form is often linked to defects in laminin-332, integrins, or related adhesion molecules. Because the defect lies at the interface that attaches the epidermis to the dermis, the skin can be extremely fragile. Some variants are severe and affect not only skin but also mucosal surfaces extensively.
In dystrophic EB, the structural failure is deeper, below the basement membrane, usually because of defective collagen VII. This protein forms anchoring fibrils that secure the basement membrane to the dermis. When it is missing or altered, repeated blistering and healing can lead to fibrosis and scarring. The scarring tendency is a major feature of this form and helps distinguish it biologically from more superficial variants.
Kindler syndrome has a mixed pattern because the affected protein participates in cell adhesion and signaling across different layers of the skin. The result is a more variable pattern of fragility and skin change. Across all forms, the degree of protein dysfunction, the tissues that depend on that protein, and the mechanical demands on those tissues determine how the disorder presents.
How the Condition Affects the Body Over Time
Over time, recurrent tissue separation and repair can reshape the skin and other epithelial surfaces. Repeated blistering leads to cycles of injury, inflammation, and healing. In some patients, this cycle creates scar tissue that is less flexible and less functional than the original tissue. In others, the dominant effect is persistent erosions and chronic barrier loss rather than dense scarring.
Long-term changes depend strongly on the subtype. Superficial forms may leave minimal scarring but still cause ongoing fragility and pain. Deeper forms can produce progressive fibrosis, contractures, and deformity because the repair process lays down collagen in a way that gradually restricts normal movement. Over time, this can affect the hands, feet, mouth, and esophagus, altering both structure and function.
Chronic barrier disruption also changes how the body interacts with its environment. The skin normally prevents fluid loss and blocks microorganisms. When that barrier is repeatedly breached, the body must divert resources toward repair and immune defense. This can lead to persistent inflammation and a higher risk of infection. The constant need for repair may also create a state of increased metabolic demand, especially in more severe disease, because tissue regeneration requires energy, amino acids, and micronutrients.
In advanced disease, long-standing inflammation and scarring can produce secondary complications in affected tissues. Narrowing of the esophagus can interfere with swallowing. Eye involvement can affect the surface of the cornea. Repeated injury to chronically damaged skin can also change its architecture and, in some forms of EB, increase the long-term risk of malignant transformation in areas subjected to relentless repair and scarring. These outcomes arise from the cumulative biology of damage and regeneration.
Conclusion
Epidermolysis bullosa is a genetically determined disorder of skin and mucosal fragility caused by defects in proteins that maintain epithelial adhesion. Its defining feature is not inflammation or infection, but structural failure at the molecular level, where skin layers should stay firmly connected under normal mechanical stress. The exact tissue level affected depends on the gene and protein involved, which is why EB includes several distinct subtypes with different patterns of severity.
Understanding EB requires seeing the skin as a biomechanical organ. The condition develops when the proteins that anchor cells and tissue layers are weakened or absent, allowing minor friction to separate the epidermis from deeper structures. From that initial defect follow the characteristic blistering, repair responses, scarring in some forms, and long-term changes in barrier function. The biology of EB is therefore a direct example of how a single class of structural proteins can determine the stability, resilience, and integrity of an entire organ system.